Zoom­ing in on a biotech lay­off; $1.9B buy­out to fill M&A void; Covid win­ners ap­point new fi­nance chiefs; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

An ex­tra en­thu­si­as­tic thank you to those of you who are read­ing this re­port dur­ing the long East­er and passover week­end. Be sure to check out our AACR cov­er­age — brought to you by John Car­roll and Max Gel­man from New Or­leans — and read Kyle LaHu­cik’s poignant fea­ture on the sto­ry be­hind one biotech among the re­cent wave of lay­offs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER